Abstract
The anthracycline antibiotics daunomycin and 14-hydroxydaunomycin (adriamycin) have been shown to be very effective in the treatment of a number of malignancies (1). Besides the non-specific side-effects of cytostatic agents, adriamycin exerts a specific toxic activity on the heart (2). This side effect may eventually lead to a life-threatening congestive heart failure when a cumulative dose of 550 mg.m-2 has been exceeded. Although the exact mechanism through which toxicity develops has not been elucidated, three major hypotheses on the pathogenesis of adriamycin induced cardiotoxicity have been postulated. As all quinones, adriamycin is a potent chelating agent for divalent cations, in particular for Ca2+ which is involved in the excitation-contraction coupling of muscle cells (3). Adriamycin can be converted to a semi-quinone either by microsomal or by mitochondrial metabolic pathways. These semiquinones give rise to the formation of free radicals, which may lead to peroxidation of polyunsaturated fatty acid structures (4). Finally, adriamycin is a strong intercalating agent, which causes an inhibition of RNA, DNA protein synthesis. Inhibition of the synthesis of contractile proteins and of reparative growth (5) will lead to a gradual decline of contractile properties of the heart.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
R.J. Blum, S.K. Carter, Ann. Int. Med., 80, 249 (1974).
E.A. Lefrak, J. Pitha et al., Cancer Chemother. Rep. part III, 6, 203 (1975).
D.W. Yesair, L. Bittman, E. Schwartzbach, Proc. Am. Ass. Cancer Res., 15, 72 (1974).
N.R. Bachur, S.L. Gordon, M.V. Gee, Mol. Pharm., 13, 901 (1977).
H.S. Schwartz, P.M. Kanter, Cancer Chemother. Rep. part III, 6, 107 (1975).
C.E. Myers, W. McGuire, R.C. Young, Cancer Treat. Rep., 60, 961 (1976).
J.G.S. Breed, A.N.E. Zimmerman, H.M. Pinedo, Proc. Am. Ass. Cancer Res., 20, 59 (1979).
A.J. Weiss, G.E. Metter, W.S. Fletcher, W.L. Wilson, T.B. Grage, G. Ramirez, Cancer Treat. Rep., 60, 813 (1976).
S.W. Kim, R.V. Petersen, J. Feijen, Polymeric Drug Delivery Systems, Dr. Design, Vol. X, Chapter 5, 193–249 (1980), Ed. by J. Ariens, Academic Press.
C. Yolles, J. Parent. Drug. Ass., 32, 188 (1978).
D.R. Cowsar in Controlled Release of Biological Active Agents (1974), A.C. Tanquary, R.E. Lacey, eds., Plenum Press.
A. Troute, Polymeric Delivery Systems (R.J. Kostelnik, ed.), pp. 157–173, Gordon and Breach Science Publishers, New York, London, Paris (1978).
H. Ringsdorf, J. Polym. Sci. Symp., no. 51, 135 (1975).
L. Bartkowski-Dodds, J.R. Daniels, Pharmacol., 4, 179 (1980).
A. Trouet, R. Baurain, D. Deprez-De Campeneere, D. Layton, M. Masquelier, Recent Results in Cancer Research, 75, 241 (1980).
A. Trouet, D. Deprez-De Campeneere, Cancer Chemother. Pharmacol., 2, 77 (1979).
A.J. Weiss, G.E. Metter, W.S. Fletcher, W.L. Wilson, T.B. Grage, G. Ramirez, Cancer Treat. Rep., 60, 813 (1976).
J.G.S. Breed, A.N.E. Zimmerman, H.M. Pinedo, Proc. Am. Ass. Cancer Res., 20, 59 (1979).
G. Atassi, M. Duarte-Karim, H.G. Tagnon, Eur. J. Cancer, 11, 309 (1975).
A. Trouet, D. Deprez-De Campeneere, C. De Duve, Nature New Biol, 239, 110 (1972).
G. Sokal, A. Trouet, J.L. Micheaux, G. Cornu, Europ. J. Canc. 9, 391.
G. Gregoniades, E.D. Neerunjun, Res. Commun. Chem. Pathol. Pharmacol., 10, 351 (1975).
E. Mayhew, D. Papahadjopoulos, Y.M. Rustum, C. Dave, Cancer Res, 36, 4406 (1976).
J.N. Weinstein, R. Blumental, S.O. Sharrow, P.A. Henhart, Biochim. Biophys Acta, 509, 272 (1978).
K.J. Widder, A.E. Senyei, B. Sears, J. Pharm. Sci., 71, 379 (1982).
T. Ghose, M.R.C. Path, S.P. Nigam, Cancer, 29, 1398 (1972).
G.F. Rowland, G.J. O’Neill, D.A.L. Davies, Nature (London), 255, 487 (1975).
G.F. Rowland, Europ. J. Cancer, 13, 593 (1977).
Y. Tsukada, W.K.D. Bischof, N. Hibi, H. Harai, E. Hurwitz, M. Sela, Proc. Natl. Acad. Sci. USA, 79, 621 (1982).
B.C.F. Chu, J.M. Whiteley, Mol. Pharmacol., 13, 80 (1979). ibid. 17, 382 (1979).
F. Levi-Schaffer, A. Bernstein, A. Meshorer, R. Arnon, Canc. Treat. Rep., 66, 107 (1982).
A. Trouet, M. Masquelier, R. Baurain, D. Deprez-De Campeneere Proc. Natl. Acad. Sci. USA, 79, 626 (1982).
G. Bardanti-Brodano, L. Fiume, Experientia, 30, 1180 (1974).
E. Hurwitz, R. Maron, R. Arnon, M. Sela, Cancer Biochem. Biophys., 1, 197 (1976).
T. Tsuruo, T. Yamori, S. Tsukagoshi, Y. Sakurai, Int. J. Cancer, 26, 655 (1980).
J. Lin, J. Li, T. Tung, J. Natl. Cancer Inst., 66, 523 (1981)
T. Kitao, K. Hattori, Nature, 265, 81 (1977).
M. Monsigny, C. Kieda, A-C. Roche, F. Delmotte, FEBS Lett, 119, 181 (1980).
W-C. Shen, H.J-P. Ryser, Biochem. Biophys. Res. Comm., 102, 1048 (1981).
M. Szekerke, R. Wade, M.E. Whisson, Neoplasma, 19, 211 (1972).
G. Franzmann, H. Ringsdorf, Makromol. Chem., 177, 2547 (1976)
P. Couvreur, B. Kante, M. Roland, P. Speiser, J. Pharm. Sci., 68, 1521 (1979).
K. Sugibayashi, M. Akimoto, Y. Morimoto, T. Nadai, Y. Kato, J. Pharm., 2, 350 (1979).
C. DeDuve, T. DeBarsy, B. Poole, A. Trouet, P. Tulkens, F. van Hoof, Biochem. Pharmacol., 23, 2495 (1974).
A. Trouet, Bull. Acad. Méd. Bel., 135, 261 (1980).
Y. Levin, B.A. Sela, FEBS Lett, 98, 119 (1979).
T. Kooistra, Endocytosis of proteins by liver cells, thesis, Rijksuniversiteit Groningen, 1979.
R. Arnon, Ther, 4, 68 (1978).
R.A. De Weger, H.F.J. Dullens, Cancer Immunol. Immunother., 8, 9 (1980).
E. Roberts et al., Cancer Res., 9, 231, 350, 645 (1949).
H. Eagle, L. Levintow, K.A. Piez, J. Biol. Chem., 227, 929 (1957) and references cited herein.
O.M. Friedman, R. Chatterji, J. Am. Chem. Soc., 81, 3750 (1958).
M. Errera, J.P. Greenstein, J. Natl. Cancer Inst., 7, 285 (1947).
H.N. Jayaram, D.A. Cooney, J.A. Ryan, G. Neil, R.L. Dion, V.H. Bono, Cancer Chemother. Rep., 59, 481 (1975).
W. Pigram, W. Fuller, L.D. Hamilton, Nature New Biol., 234, 78 (1971).
F. Zuzino, R. Gambetta, A. DiMarco, A. Zaccara, Biochem. Biophys. Acta, 277, 489 (1972).
A. DiMarco, F. Zuzino, R. Silvestrini, C. Gambarucci, R.A. Gambetta, Biochem. Pharmacol., 20, 1323 (1971).
T.A. Connors, Chem. and Ind., 477 (1980).
S. Tsuchida, K. Hoshino, T. Sato, N. Ito, K. Sato, Cancer Res. 39, 4200 (1979).
R. Cameron, J. Kellen, A. Kolin, A. Malkin, E. Farber, Cancer Res., 38, 823 (1978).
T.A. Connors, New Developments in Cancer Chemotherapy (Workshop on Pharmacology and Toxicology with special relevance to early trials, Academic Hospital of the Free University, Amsterdam), 12–13 Dec., 1980.
E.H. Cooper, R. Turner, L. Steele et al., Br. J. Cancer, 31, 111 (1975).
G.P. Sachdev. G. Wen, B. Martin, G.S. Kishore, O.F. Fox, Proc. Okla. Acad. Sci., 60 (1980).
G.P. Sachdev, G. Wen, B. Martin, G.S. Kishore, O.F. Fox, Cancer Biochem. Biophys., 5, 15 (1980).
S. Jaken, M. Mason, Proc. Natl. Acad. Sci., 75, 1750 (1978).
R.G. Poser, F.M. Sirotnak, P.L. Chello, Proc. Am. Assoc. Cancer Res., 21, 303 (1980).
L.M. De Young, W.L. Richards, W. Bonzelet, L.L. Tsai, R.K. Boutwell, Cancer Res., 38, 3697 (1978).
B. States, S. Segal, Life Sci., 27, 1985 (1980).
S. Takahasi, R. Suzanne Zakin, H.M. Steinman, Arch. Biochem. Biophys., 207, 87 (1981).
D. Munjal, P. Chawla, J.J. Lokich, N. Zamcheck, Cancer, 37, 1800 (1976).
M.K. Schwartz, Clin. Chem., 19, 10 (1973).
D.D. Munjal, Clin. Chem., 26, 1809 (1980).
T.J. Peters, C.A. Seymour, G. Wells et al., Br. Med. J., 1576 (1977).
N. Takeishi, T. Higashi, T. Nomura et al., Gann., 67, 215 (1976).
P.L. Carl, P.K. Chakravarty, J.A. Katzenellenbogen, M.J. Weber, Proc. Natl. Acad. Sci., 77, 2224 (1980).
. E.R. Blout, R.H. Karlson, J. Am. Chem. Soc., 78, 941 (1956).
W.E. Hanby, S.G. Waley, J. Watson, J. Chem. Soc., 3239 (1950).
E.R. Blout, M. Idelson, J. Am. Chem. Soc., 78, 497 (1956).
M. Idelson, E.R. Blout, J. Am. Chem. Soc., 80, 4631 (1958).
C.P. Lillya, W.J. MacKnight, R.M. Newman, W.A. Su, P. Uden, J. Macromol. Sci. Chem., A14, 1181 (1980).
W.A.R. van Heeswijk, M.J.D. Eenink, J. Feijen, Synthesis, 744 (1982).
R. Ledger, F.H.C. Stewart, Austr. J. Chem., 18, 1477 (1965).
B. Belleau, G. Malek, J. Amer. Chem. Soc., 90, 1651 (1968).
Y. Kiso, H. Yajima, J. Chem. Soc. Chem. Comm., 949 (1972).
K. Weber, M. Osborn, J. Biol. Chem., 244, 4406 (1969).
G. Canevazzi, A. Di Marco, M. Gaetani, A. Grein, P. Orezzi, Ger. Pat. 1, 920, 198, Chem. Abstract, 72, 90832 (1970).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag US
About this chapter
Cite this chapter
van Heeswijk, W.A.R. et al. (1984). Synthesis, Characterization and Antitumor Activity of Macromolecular Prodrugs of Adriamycin. In: Anderson, J.M., Kim, S.W. (eds) Recent Advances in Drug Delivery Systems. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2745-5_6
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2745-5_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9700-0
Online ISBN: 978-1-4613-2745-5
eBook Packages: Springer Book Archive